Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary M Horowitz

Showing results (71-80 of 260) with videos related to

Pageof 26
Sort By:
Blood|February 3, 2005
Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control studyRochelle E Curtis, Catherine Metayer, J Douglas Rizzo, et al.
Blood|December 16, 2004
Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United StatesFausto R Loberiza, Mei-Jie Zhang, Stephanie J Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2007
Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controlsMichelle M Bishop, Jennifer L Beaumont, Elizabeth A Hahn, et al.
The Lancet. Haematology|May 30, 2025
Beyond maximum grade: tolerability of immunotherapies, cellular therapies, and targeted agents in haematological malignanciesPaul J Bröckelmann, Edward R Scheffer Cliff, Gloria Iacoboni, et al.
Blood|June 17, 2011
Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemiaMary Eapen, Jennifer Le Rademacher, Joseph H Antin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 8, 2017
Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation OutcomesMary Eapen, Joanne Kurtzberg, Mei-Jie Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantationMichael A Andrykowski, Michelle M Bishop, Elizabeth A Hahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2014
Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)C Alan Howard, Marcelo A Fernandez-Vina, Frederick R Appelbaum, et al.
Cancer|October 27, 2017
PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivorsBronwen E Shaw, Karen L Syrjala, Lynn E Onstad, et al.
Blood|May 28, 2020
Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?Matthew J Frigault, Sarah Nikiforow, Michael K Mansour, et al.
Pageof 26

Showing results (71-80 of 260) with videos related to

Sort By:
Pageof 26
Blood|February 3, 2005
Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control studyRochelle E Curtis, Catherine Metayer, J Douglas Rizzo, et al.
Blood|December 16, 2004
Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United StatesFausto R Loberiza, Mei-Jie Zhang, Stephanie J Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2007
Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controlsMichelle M Bishop, Jennifer L Beaumont, Elizabeth A Hahn, et al.
The Lancet. Haematology|May 30, 2025
Beyond maximum grade: tolerability of immunotherapies, cellular therapies, and targeted agents in haematological malignanciesPaul J Bröckelmann, Edward R Scheffer Cliff, Gloria Iacoboni, et al.
Blood|June 17, 2011
Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemiaMary Eapen, Jennifer Le Rademacher, Joseph H Antin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 8, 2017
Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation OutcomesMary Eapen, Joanne Kurtzberg, Mei-Jie Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantationMichael A Andrykowski, Michelle M Bishop, Elizabeth A Hahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2014
Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)C Alan Howard, Marcelo A Fernandez-Vina, Frederick R Appelbaum, et al.
Cancer|October 27, 2017
PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivorsBronwen E Shaw, Karen L Syrjala, Lynn E Onstad, et al.
Blood|May 28, 2020
Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?Matthew J Frigault, Sarah Nikiforow, Michael K Mansour, et al.
Pageof 26